Jonas Samuel Jutzi, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myeloproliferative Disorders | 13 | 2023 | 603 | 3.850 |
Why?
|
| Calreticulin | 2 | 2022 | 97 | 1.630 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 3 | 2021 | 182 | 1.450 |
Why?
|
| NF-E2 Transcription Factor, p45 Subunit | 4 | 2023 | 58 | 1.360 |
Why?
|
| Janus Kinase 2 | 7 | 2023 | 527 | 1.200 |
Why?
|
| Primary Myelofibrosis | 1 | 2022 | 214 | 0.750 |
Why?
|
| Sarcoma, Myeloid | 1 | 2019 | 59 | 0.650 |
Why?
|
| Cell Transformation, Neoplastic | 3 | 2019 | 2940 | 0.610 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2022 | 1333 | 0.560 |
Why?
|
| Mutation | 9 | 2023 | 29717 | 0.480 |
Why?
|
| Bone Marrow Neoplasms | 1 | 2013 | 104 | 0.420 |
Why?
|
| Leukemia, Myeloid | 1 | 2015 | 705 | 0.420 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2021 | 1351 | 0.400 |
Why?
|
| Hematologic Neoplasms | 2 | 2020 | 1820 | 0.390 |
Why?
|
| Hematopoiesis | 1 | 2020 | 2066 | 0.370 |
Why?
|
| Bone Marrow | 1 | 2020 | 2941 | 0.360 |
Why?
|
| Leukemia, Myeloid, Acute | 3 | 2023 | 3497 | 0.360 |
Why?
|
| Tumor Microenvironment | 1 | 2020 | 3564 | 0.320 |
Why?
|
| Neoplasm Proteins | 1 | 2020 | 3691 | 0.310 |
Why?
|
| Receptors, Thrombopoietin | 1 | 2022 | 156 | 0.200 |
Why?
|
| Interleukin-13 | 1 | 2022 | 389 | 0.190 |
Why?
|
| Glycosylation | 1 | 2022 | 1123 | 0.170 |
Why?
|
| Interleukin-4 | 1 | 2022 | 1146 | 0.170 |
Why?
|
| Inflammation | 2 | 2016 | 10578 | 0.170 |
Why?
|
| Methylation | 1 | 2021 | 1107 | 0.170 |
Why?
|
| Signal Transduction | 3 | 2020 | 23387 | 0.160 |
Why?
|
| bcl-X Protein | 1 | 2020 | 411 | 0.160 |
Why?
|
| Cytoplasm | 1 | 2022 | 1539 | 0.160 |
Why?
|
| Mice | 10 | 2023 | 81045 | 0.150 |
Why?
|
| Hematopoietic Stem Cells | 4 | 2020 | 3381 | 0.150 |
Why?
|
| Gene Knockout Techniques | 1 | 2020 | 808 | 0.140 |
Why?
|
| Epigenesis, Genetic | 2 | 2021 | 3639 | 0.140 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2019 | 651 | 0.140 |
Why?
|
| Neoplasms | 2 | 2022 | 21596 | 0.130 |
Why?
|
| Erythropoiesis | 1 | 2020 | 705 | 0.130 |
Why?
|
| Animals | 11 | 2023 | 168561 | 0.130 |
Why?
|
| Embryonic Development | 1 | 2020 | 704 | 0.130 |
Why?
|
| Transforming Growth Factor beta | 1 | 2022 | 2006 | 0.130 |
Why?
|
| Histones | 2 | 2021 | 2597 | 0.120 |
Why?
|
| Clone Cells | 2 | 2016 | 1692 | 0.110 |
Why?
|
| Cyclooxygenase 2 | 1 | 2015 | 611 | 0.110 |
Why?
|
| Dinoprostone | 1 | 2015 | 600 | 0.110 |
Why?
|
| NF-E2 Transcription Factor | 1 | 2012 | 40 | 0.110 |
Why?
|
| Chromosome Aberrations | 1 | 2019 | 1811 | 0.100 |
Why?
|
| Protein Stability | 1 | 2013 | 556 | 0.100 |
Why?
|
| Mutant Proteins | 1 | 2013 | 500 | 0.100 |
Why?
|
| Cell Proliferation | 3 | 2018 | 10472 | 0.090 |
Why?
|
| Glucose | 1 | 2022 | 4391 | 0.090 |
Why?
|
| Immune System | 1 | 2015 | 804 | 0.090 |
Why?
|
| Humans | 19 | 2023 | 742088 | 0.090 |
Why?
|
| Mice, Transgenic | 3 | 2023 | 9735 | 0.080 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2019 | 2948 | 0.080 |
Why?
|
| Gene Expression | 2 | 2018 | 7790 | 0.070 |
Why?
|
| Transcriptional Activation | 1 | 2013 | 1782 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2021 | 8425 | 0.070 |
Why?
|
| Gene Expression Regulation | 3 | 2023 | 12071 | 0.070 |
Why?
|
| Protein Binding | 2 | 2018 | 9387 | 0.060 |
Why?
|
| Bone Marrow Transplantation | 1 | 2013 | 2763 | 0.060 |
Why?
|
| Disease Models, Animal | 2 | 2015 | 18006 | 0.060 |
Why?
|
| Mice, Knockout | 1 | 2020 | 14554 | 0.060 |
Why?
|
| Cytokines | 2 | 2018 | 7317 | 0.060 |
Why?
|
| Cell Lineage | 1 | 2013 | 2504 | 0.060 |
Why?
|
| HEK293 Cells | 1 | 2013 | 4200 | 0.060 |
Why?
|
| Cell Line, Tumor | 1 | 2020 | 16665 | 0.060 |
Why?
|
| Case-Control Studies | 1 | 2020 | 21719 | 0.050 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2020 | 5425 | 0.050 |
Why?
|
| Histone Demethylases | 1 | 2023 | 320 | 0.050 |
Why?
|
| DNA | 1 | 2013 | 7289 | 0.040 |
Why?
|
| Benzothiazoles | 1 | 2020 | 247 | 0.040 |
Why?
|
| Erythroid Cells | 1 | 2020 | 238 | 0.040 |
Why?
|
| Isoquinolines | 1 | 2020 | 368 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2013 | 13029 | 0.040 |
Why?
|
| Antigens, CD34 | 1 | 2020 | 657 | 0.040 |
Why?
|
| Oxidoreductases, N-Demethylating | 1 | 2018 | 115 | 0.040 |
Why?
|
| Polycythemia Vera | 1 | 2018 | 163 | 0.030 |
Why?
|
| K562 Cells | 1 | 2018 | 632 | 0.030 |
Why?
|
| Transgenes | 1 | 2019 | 1009 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2020 | 1655 | 0.030 |
Why?
|
| Thrombasthenia | 1 | 1994 | 24 | 0.030 |
Why?
|
| Leishmaniasis, Visceral | 1 | 1995 | 93 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 57683 | 0.030 |
Why?
|
| Pneumonia, Pneumocystis | 1 | 1995 | 247 | 0.030 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 1994 | 293 | 0.030 |
Why?
|
| Young Adult | 1 | 2019 | 56350 | 0.030 |
Why?
|
| Male | 4 | 2020 | 349538 | 0.030 |
Why?
|
| Transplantation, Heterologous | 1 | 2020 | 2382 | 0.020 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 1995 | 654 | 0.020 |
Why?
|
| Fibrinogen | 1 | 1994 | 894 | 0.020 |
Why?
|
| Blood Cell Count | 1 | 2012 | 402 | 0.020 |
Why?
|
| Adolescent | 1 | 2019 | 85649 | 0.020 |
Why?
|
| Fracture Fixation, Intramedullary | 1 | 1992 | 156 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2018 | 6313 | 0.020 |
Why?
|
| Blood Cells | 1 | 2012 | 309 | 0.020 |
Why?
|
| Femoral Fractures | 1 | 1992 | 376 | 0.020 |
Why?
|
| Aged | 2 | 2019 | 162944 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2018 | 8436 | 0.020 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2012 | 789 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2018 | 5867 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2016 | 1788 | 0.020 |
Why?
|
| Hip Prosthesis | 1 | 1992 | 917 | 0.020 |
Why?
|
| Adult | 2 | 2019 | 213712 | 0.020 |
Why?
|
| Middle Aged | 1 | 2019 | 213127 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2018 | 4282 | 0.010 |
Why?
|
| Blood Platelets | 1 | 1994 | 2506 | 0.010 |
Why?
|
| Leukemia | 1 | 2012 | 1507 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 21821 | 0.010 |
Why?
|
| Models, Biological | 1 | 2018 | 9581 | 0.010 |
Why?
|
| Female | 1 | 2019 | 379592 | 0.010 |
Why?
|
| Chromatin | 1 | 2012 | 2917 | 0.010 |
Why?
|
| Candidiasis, Oral | 1 | 1995 | 60 | 0.010 |
Why?
|
| Disease Progression | 1 | 2012 | 13256 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2012 | 11470 | 0.010 |
Why?
|
| Phenotype | 1 | 2012 | 16331 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 1994 | 1456 | 0.010 |
Why?
|
| Platelet Aggregation | 1 | 1994 | 800 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 1992 | 15244 | 0.010 |
Why?
|
| Point Mutation | 1 | 1994 | 1624 | 0.010 |
Why?
|
| Reference Values | 1 | 1994 | 4982 | 0.000 |
Why?
|
| Prosthesis Failure | 1 | 1992 | 1203 | 0.000 |
Why?
|
| Kinetics | 1 | 1994 | 6474 | 0.000 |
Why?
|
| Binding Sites | 1 | 1994 | 6115 | 0.000 |
Why?
|
| Flow Cytometry | 1 | 1994 | 5975 | 0.000 |
Why?
|
| Reoperation | 1 | 1992 | 4200 | 0.000 |
Why?
|
| Amino Acid Sequence | 1 | 1994 | 13814 | 0.000 |
Why?
|
| Peptide Fragments | 1 | 1994 | 5095 | 0.000 |
Why?
|
| Molecular Sequence Data | 1 | 1994 | 18112 | 0.000 |
Why?
|
| Radiography | 1 | 1992 | 7010 | 0.000 |
Why?
|
| Diagnosis, Differential | 1 | 1995 | 12958 | 0.000 |
Why?
|
| Antibodies, Monoclonal | 1 | 1994 | 9274 | 0.000 |
Why?
|